JP2017523781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017523781A5 JP2017523781A5 JP2017505552A JP2017505552A JP2017523781A5 JP 2017523781 A5 JP2017523781 A5 JP 2017523781A5 JP 2017505552 A JP2017505552 A JP 2017505552A JP 2017505552 A JP2017505552 A JP 2017505552A JP 2017523781 A5 JP2017523781 A5 JP 2017523781A5
- Authority
- JP
- Japan
- Prior art keywords
- aptamer
- nucleic acid
- seq
- dimer
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091023037 Aptamer Proteins 0.000 claims 32
- 108091008104 nucleic acid aptamers Proteins 0.000 claims 15
- 239000000539 dimer Substances 0.000 claims 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical group 0.000 claims 7
- 239000002202 Polyethylene glycol Substances 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 3
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 238000010494 dissociation reaction Methods 0.000 claims 1
- 230000005593 dissociations Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 208000015347 renal cell adenocarcinoma Diseases 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462031427P | 2014-07-31 | 2014-07-31 | |
| US62/031,427 | 2014-07-31 | ||
| PCT/US2015/043162 WO2016019270A1 (en) | 2014-07-31 | 2015-07-31 | An antagonistic pd-1 aptamer and its applications in cancer therapy related applications |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017523781A JP2017523781A (ja) | 2017-08-24 |
| JP2017523781A5 true JP2017523781A5 (cg-RX-API-DMAC7.html) | 2018-09-13 |
| JP6680760B2 JP6680760B2 (ja) | 2020-04-15 |
Family
ID=55218360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017505552A Expired - Fee Related JP6680760B2 (ja) | 2014-07-31 | 2015-07-31 | アンタゴニストｉｃ ｐｄ−１アプタマー及びその癌治療関連用途への応用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10329570B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3174985A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6680760B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20170055474A (cg-RX-API-DMAC7.html) |
| CN (1) | CN107002083A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2956718A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI703214B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016019270A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018000917A2 (pt) | 2015-07-16 | 2018-09-11 | Bioxcel Therapeutics Inc | abordagem inovadora para o tratamento de câncer através da imunomodulação |
| EP3416690A4 (en) | 2016-02-19 | 2020-02-19 | City of Hope | BISPECIFIC APTAMER |
| JP2019534708A (ja) * | 2016-09-06 | 2019-12-05 | ザ メソディスト ホスピタル システム | Ｐｄ−１特異的アプタマー |
| CN109982707A (zh) * | 2016-09-16 | 2019-07-05 | 杜克大学 | 血管性血友病因子（vwf）靶向剂及其使用方法 |
| CN107794267B (zh) * | 2017-03-14 | 2021-03-26 | 湖南大学 | 一种靶向pd1-pdl1的双特异性核酸适体及其衍生物 |
| CN111542326B (zh) | 2017-08-11 | 2024-06-04 | 希望之城 | 转铁蛋白受体(TfR)的RNA适体 |
| US11007211B2 (en) * | 2018-01-07 | 2021-05-18 | City Of Hope | CCR7 aptamers and uses thereof |
| EP3683310A1 (en) | 2019-01-21 | 2020-07-22 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamer and use of the aptamer in the diagnosis and treatment of cancer |
| CN111154765B (zh) * | 2019-12-30 | 2023-08-01 | 广西医科大学 | T细胞免疫检查点pd-1的适配体筛选、鉴定方法及抗肿瘤应用 |
| KR20220148867A (ko) | 2020-03-03 | 2022-11-07 | 어레이 바이오파마 인크. | (R)-N-(3-플루오로-4-((3-((1-히드록시프로판-2-일)아미노)-1H-피라졸로[3,4-b]피리딘-4-일)옥시)페닐)-3-(4-플루오로페닐)-1-이소프로필-2,4-디옥소-1,2,3,4-테트라히드로피리미딘-5-카르복스아미드를 사용하여 암을 치료하는 방법 |
| CN111593053B (zh) * | 2020-05-27 | 2022-02-15 | 武汉大学 | 识别人程序性死亡受体1的dna适配体及方法和应用 |
| US20240417738A1 (en) * | 2021-10-22 | 2024-12-19 | Ohio State Innovation Foundation | Immunotherapies for the treatment of cancer |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| AU1959897A (en) * | 1996-02-22 | 1997-09-10 | Board Of Trustees Of Michigan State University | Gene specific universal mammalian sequence-tagged sites |
| EP1268856A2 (de) * | 2000-04-07 | 2003-01-02 | Epigenomics AG | Detektion von snp's und cytosin-methylierungen |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US8039443B2 (en) * | 2002-11-21 | 2011-10-18 | Archemix Corporation | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| JP2006516151A (ja) * | 2002-11-21 | 2006-06-22 | アーケミックス コーポレイション | 改良された薬力学的特性を有する多価アプタマー治療剤ならびにそれらの作製方法および使用法 |
| CA2523260A1 (en) | 2003-04-21 | 2004-11-04 | Archemix Corporation | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| BRPI0614961A2 (pt) * | 2005-08-26 | 2016-09-13 | Archemix Corp | aptâmero, método, e, composição |
| EP2015758B1 (en) * | 2006-05-05 | 2014-04-02 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression apob |
| EP2406396A2 (en) * | 2009-03-12 | 2012-01-18 | Brainco Biopharma, S.L. | A genotyping tool for improving the prognostic and clinical management of ms patients |
| US20130209514A1 (en) * | 2009-06-09 | 2013-08-15 | Eli Gilboa | Aptamer-targeted costimulatory ligand aptamer |
| EP2354247A1 (en) * | 2010-02-11 | 2011-08-10 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | Means and methods for typing a sample for rheumatoid arthritis or spondyloarthritis |
| WO2013012921A2 (en) * | 2011-07-20 | 2013-01-24 | University Of Iowa Research Foundation | Nucleic acid aptamers |
| CN104145020B (zh) * | 2012-02-16 | 2020-06-02 | 先正达参股股份有限公司 | 工程化的杀有害生物蛋白质 |
| US20150086584A1 (en) * | 2012-03-22 | 2015-03-26 | University Of Miami | Multi-specific binding agents |
| EP2850185A4 (en) * | 2012-05-16 | 2015-12-30 | Rana Therapeutics Inc | COMPOSITIONS AND METHOD FOR MODULATING UTRN GENE EXPRESSION |
| CA2928520C (en) * | 2012-10-23 | 2023-03-14 | Caris Life Sciences Switzerland Holdings, S.A.R.L. | Aptamers and uses thereof |
| BR112015010106A2 (pt) * | 2012-11-05 | 2017-08-22 | Pronai Therapeutics Inc | Dosagem e administração de terapias para câncer com oligonucleotídeo |
| EP2922861A4 (en) | 2012-11-26 | 2016-09-14 | Caris Life Sciences Switzerland Holdings Gmbh | BIOMARKER COMPOSITIONS AND METHODS |
| US11254933B2 (en) * | 2014-07-14 | 2022-02-22 | The Regents Of The University Of California | CRISPR/Cas transcriptional modulation |
-
2015
- 2015-07-31 KR KR1020177005533A patent/KR20170055474A/ko not_active Withdrawn
- 2015-07-31 CA CA2956718A patent/CA2956718A1/en not_active Abandoned
- 2015-07-31 US US15/500,354 patent/US10329570B2/en active Active
- 2015-07-31 WO PCT/US2015/043162 patent/WO2016019270A1/en not_active Ceased
- 2015-07-31 JP JP2017505552A patent/JP6680760B2/ja not_active Expired - Fee Related
- 2015-07-31 TW TW104124956A patent/TWI703214B/zh not_active IP Right Cessation
- 2015-07-31 CN CN201580041386.3A patent/CN107002083A/zh active Pending
- 2015-07-31 EP EP15828285.5A patent/EP3174985A4/en not_active Withdrawn